• McPhailMark J WMJWLiver Intensive Therapy Unit, Institute of Liver Studies, King's College Hospital, Denmark Hill, London, United Kingdom., Francesca Parrott, Julia A Wendon, David A Harrison, Kathy A Rowan, and William Bernal.
• Liver Intensive Therapy Unit, Institute of Liver Studies, King's College Hospital, Denmark Hill, London, United Kingdom.
• Crit. Care Med. 2018 May 1; 46 (5): 705712705-712.

ObjectiveTo assess the epidemiology and outcome of patients with cirrhosis following critical care unit admission.DesignRetrospective cohort study.SettingCritical care units in England, Wales, and Northern Ireland participating in the U.K. Intensive Care National Audit and Research Centre Case Mix Programme.PatientsThirty-one thousand three hundred sixty-three patients with cirrhosis identified of 1,168,650 total critical care unit admissions (2.7%) admitted to U.K. critical care units between 1998 and 2012.InterventionsNone.Measurements And Main ResultsTen thousand nine hundred thirty-six patients had alcohol-related liver disease (35%). In total, 1.6% of critical care unit admissions in 1998 had cirrhosis rising to 3.1% in 2012. The crude critical care unit mortality of patients with cirrhosis was 41% in 1998 falling to 31% in 2012 (p < 0.001). Crude hospital mortality fell from 58% to 46% over the study period (p < 0.001). Mean(SD) Acute Physiology and Chronic Health Evaluation II score in 1998 was 20.3 (8.5) and 19.5 (7.1) in 2012. Mean Acute Physiology and Chronic Health Evaluation II score for patients with alcohol-related liver disease in 2012 was 20.6 (7.0) and 19.0 (7.2) for non-alcohol-related liver disease (p < 0.001). In adjusted analysis, alcohol-related liver disease was associated with increased risk of death (odds ratio, 1.51 [95% CI, 1.42-1.62; p < 0.001]) with a year-on-year reduction in hospital mortality (adjusted odds ratio, 0.95/yr, [0.94-0.96, p < 0.001]).ConclusionsMore patients with cirrhosis are being admitted to critical care units but with increasing survival rates. Patients with alcohol-related liver disease have reduced survival rates partly explained by higher levels of organ failure at admission. Patients with cirrhosis and organ failure warrant a trial of organ support and universal prognostic pessimism is not justified.

34 keywords...

hide…